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Summary.-Arginase activity was found to be increased in precancerous nodules
and mammary tumour when compared with the mammary gland. Proline inhibited
the mammary tumour arginase and up to 30 mmol concentration the inhibition
follows first order kinetics. Hill analysis of the inhibition of arginase by proline
showed that proline inhibits the arginase activity by competing directly at the
active site without conformational change. The inhibition may be of regulatory
importance, involving a feedback mechanism in mammary tumours.
SYNTHESIS of proline from arginine
has been reported in bacteria] and animal
systems (Costilow and Laycock, 1971;
Peisach and Strecker, 1962; Strecker,
1965; Eliasson and Strecker, 1966; Hill
and Chambers, 1967; Reddy and Camp-
bell, 1.969; Kaysen and Strecker, 1973).
In mammary gland a major conversion of
labelled arginine into proline occurs,
without formation of labelled citrulline
(Mepham and Linzell, 1966, 1967). It has
also been reported that in the mammary
gland, during lactation, the arginase
activity does not function as part of the
urea cycle (Folley and Greenbaum, 1947;
Greengard, Sahib and Knox, 1970; Yip
and Knox, 1972). This suggests that the
urea cycle is inoperative in mammary
gland and that arginine can be diverted
throughthe reactions ofarginase, ornithine
aminotransferase and A1-pyrroline 5-car-
boxylate reductase to the synthesis of
proline, and proline is the end product of
the metabolic conversion of arginine.
In the present study, we were interested
in investigating the effects of glutamic
acid and proline on arginase activity in
mouse mammary tumours. The model
was chosen because mouse mammary
tumours of several strains are known to
contain high arginase activity (Bach and
Lasnitzki, 1947; Bhide, 1971).
MATERIALS AND METHODS
Preparation of tissue extracts.-Seven- to
9-month old mice of ICRC strain (Ranadive
et al., 1961) bearing spontaneous mammary
tumours were used for experimental pur-
poses. Mammary glands from normal and
tumour bearing mice of ICRC strain were
also used. Mice were killed by cervical
dislocation and mammary gland (normal and
tumour bearing) and the tumours were
dissected out and chilled in an ice bath.
After washing in cold Tyrode's balanced salt
solution and blotting on the filter paper, the
tissue was weighed and homogenized in the
cold 0-025 mol/l sodium glycinate (pH 9 5)
to make a 10% (w/v) extract. The homo-
genates were then centrifuged at 2000 rev/
min in the cold. The fat which accumulated
at the top of the homogenate was carefully
removed and the supernatant was used as the
source of enzyme.
Arginase assay. Arginase activity in the
tissue extracts was determined as described
by Kesava Rao, Reddy and Swami (1973).
The reaction mixture contained 80 ,umol
L-arginine (pH 9 5), 100 tzmol sodium glyci-
nate (pH 9 5), 1 ,umol MnCl2, and 01 ml
enzyme extract in a total volume of 1 ml.
After an incubation of 30 min at 37°C the
reaction Mwas stopped by adding 5 ml of 0 5
mol/l HC1O4. Urea in aliquots of the
deproteinized reaction mixtures was estimated
colorimetrically by the method of Archibald
(1945). Because certain chemical compounds
interfere with the colour reaction of thisK. V. KESAVA RAG, S. R. PAI AND C. V. BAPAT
method, urea standards were prepared in the
presence of the exact amounts of each of
the assay mixture components present in the
aliquot taken for urea determination. When
amino acids were tested for their effects on
arginase activity, they were pre-adjusted to
the experimental pH.
Protein determination.-The protein con-
tent in the enzyme extracts was determined
by the method of Lowry et al. (1951).
Kinetic parameters.-The slopes, Vm, and
Michaelis constants (Km) were calculated by
the method of least squares. The inhibitor
constants (Ki) were calculated by the
method of Dixon and Webb (1964) using the
formula:
Ki 1 where K_p_/Km) - 1
i = inhibitor concentration
Kp = apparent Michaelis constant
Km = Michaelis constant.
Acetone dried powders.-Acetone powders
were prepared as described by Campbell
(1966).
RESULTS
Aryinase activity
All the enzyme assays were carried out
under conditions which measured initial
velocities. Table I shows the arginase
activity in mammary glands from normal
and tumour bearing mice andin mammary
tumour. The enzyme activity was found
to be greater in the mammary glands of
tumour bearing animals and in the
mammary tumour when compared with
the normal mammary gland (Table I).
Similar increase of arginase activity asso-
ciated with cellular proliferation and
mammary tumours has been reported
earlier (Smith and Richterich, 1957; Bach
and Lasnitzki, 1947; Bach and Simon-
Reuss, 1953; Bhide, 1971).
Proline inhibition
Of the 3 amino acids studied at 40
mmol concentration on the mammary
tumour arginase, proline showed 28%
inhibition of arginase activity (Table II).
Hydroxyproline showed 10% inhibition
whereas glutamic acid had an insignificant
effect on arginase activity (Table II).
Proline showed 23% inhibition ofarginase
activity with acetone dried powders (Table
II).
The effect of proline was studied at
different concentrations of arginine (Fig.
1). The plots were linear up to 30 mmol
proline at 3 arginine concentrations studied
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TABLE I.-Arginase Activity in Mammary
Tissues and Mammary Tumour
Arginase %
activity Activation
Mammary gland 0 774±0
(control)
Mammary gland 2*56±0*56
(tumour bearing)
Mammary tumour 4- 8±0 26
231
520
Each value represents the mean ±S.D. of
4 determinations of enzyme activity.
Enzyme activity expressed in /Lmol urea/h/mg
protein.
10 20 30 40
L-PROLINE (mmol.)
FIG. 1.-Effect of proline onarginase activity
at different concentrations of arginine (a)
20 mmol arginine, (b) 40 mmol arginine, (c)
80 mmol arginine.
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TABLE II.-Effect of Proline, Hydroxy-
proline and Glutamic Acid on Arginase
Activity in Mouse Mammary Tumour
Homogenates and Acetone Dried Powder
(Fig. 1), thus indicating that up to 30
mmol proline the reaction follows first
order kinetics.
Amino acid
40 mmol
Homogenates
Control
L-proline
L-hydroxyproline
L-glutamic acid
**Acetone dried powders
Control
L-proline
L-hydroxyproline
L-glutamic acid
Arginase Percentage
activity change*
10 95
7-86
9-87
11 105
45- 44
34- 88
42- 88
48- 32
Arginase activity expressedl in ,umol urea/h/mg
protein.
* + denotes activation anl -denotes inhibition
of arginase activity.
** For all the experiments 1 g of the acetone
powder was homogenized with 1O ml of cold 0 01
mol/l tris-HCl buffer (pH 7- 5), after 30 min stay at
4°C the extraction was repeated and the combinedl
supernatants were use(l as source of enzyme.
(a)
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0*7
0-6
0-5
0-3
0-2
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Kinetics ofproline inhibition
The kinetics of inhibition of arginase
by proline is shown in the form of the
Lineweaver-Burk double reciprocal plot
and as well as the Dixon plot (Fig. 2a, b).
The inhibition of arginase by proline
shows peculiar kinetics. Although a com-
petitive inhibition on the whole, this
amino acid gave non-linear reciprocal
plots tending towards non-competitive
inhibition at lower substrate concen-
trations (Fig. 2a). The experiment was
repeated with acetone dried powders to
check the possibility ofinterference by the
small ions and free amino acids present
in the homogenate on the inhibition of
(b)
=0
0-02 0 06 0.1 014 0-18 0-2 0 10 20 30 40
1 -1 L-PROLINE (m mol)
[m mol ]
ARGININE,
Fia.. 2.-(a) Lineweaver-Burk double reciprocal plot showing the competitive inhibition of arginase by
proline. (b) Inhibition of arginase by proline at 3 levels of substrate (Dixon Plot).
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arginase activity by proline. The mode of
inhibition was found to be same with
acetone powders, indicating that inter-
ference due to small molecules is unlikely.
The Dixon plot (Fig. 2b) also showed a
tendency towards a mixed type of inhibi-
tion (Dixon and Webb, 1964). Similar
deviation from the classic Michaelis Men-
ten kinetics was reported for the inhibition
of frog liver glutamate dehydrogenase by
alanine (Wiggert and Cohen, 1965); hepa-
tic tryptophan oxygenase by a-methyl-
tryptophan (Schutz, Chow and Feigelson,
TABLE III.-Kinetic Parameters of Inhibi-
tion of Arginase by L-proline
L-proline concentration
........
0 10 mmol 20 mmol
Slope 1 226 2- 552 2 - 732
Km 6-14 mmol 9-18 mmol 9 98 mmol
Vm 5 00 3-91 3-35
Ki 20* 2 mmol 32 0 mmol
20
1 0
5
I
E 1.0
0*5
1972) and sheep liver arginase byisoleucine
(Kesava Rao, Reddy and Swami, 1973).
The Km was found to be 6 14 mmol
for mammary tumour arginase (Table III).
An increase in Km and a decrease in Vm
was observed in the presence of proline,
thus indicating the competitive inhibition
(Table III). The average Ki value was
found to be 26-1 mmol for proline (Table
III). The Km valuesreportedby different
workers for liver arginase from different
species vary from 2 mmol to 40 mmol
(Mora et al., 1965; Campbell, 1966;
Hirsch-Kolb et al., 1970; Schimke, 1964).
The Km value for ox brain arginase is
9 mmol (Gasiorowska, Porembska and
Mochnacha, 1969).
The non-linear kinetics with respect
to arginine concentration probably sug-
gest the presence of co-operative interac-
tions. The data in Fig. 2a were replotted
according to the Hill eqtuationi (Fig. 3),
0 0
4*/'
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O e 0
I I I I I l1 I I I I III1I
I 5 10 20 3040 100
L-ARGININE ( m mol )
Fm,. 3. Hill Plot of arginiase activity as a function of the concentration of the arginine. The
calculate(d slope valuies (n) are shown. The data used here for the Hill Plot are the same as in
Fig. 2a.
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which gave a straight line with Hill
coefficient (n) of 1D0 for the arginase, both
in the presence and absence of proline.
AHill coefficient greaterthanone indicates
positive co-operativity, less than one
negative co-operativity and equal to one
non-interacting sites (Koshland, 1970).
The present study therefore indicates that
proline inhibits the arginase activity by
competing directly at the active site
without conformational change (Koshland,
1970).
The plot of (Vo - v)/v versus concen-
tration of proline (Fig. 4) also showed a
tendency towards straight lines with slope
values (n) 1D0 at 3 arginine concentrations
studied, thus confirming that proline
competes with arginine for the catalytic
site of arginase with no apparent gross
co-operativity.
2.0
1-O
0
0o5
0-4
0.3
0.2
0
DISCUSSION
The inhibition ofarginase by proline is
of particular interest. Arginine, which is
the substrate for arginase, is a branched
chain amino acid containing 6 carbon
atoms, whereas proline is a heterocyclic
amino acid. Thus apparently there is no
structural relationship between arginine
and proline but proline shows competitive
inhibition of arginase. Mammalian liver
homogenates can convert proline to orni-
thine by the enzymes proline oxidase and
ornithine aminotransferase (Smith, Benzi-
man and Strecker, 1967). Ornithine is an
inhibitor of arginase (Kesava Rao, Reddy
and Swami, 1973). However, it is doubt-
ful whether this pathway is operative in
mammarytumourandevenifitisoperative
it is unlikely that enough ornithine would
be formed from the proline added to the
0
qo /
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I I l l
10 20 30 40 50
L-PROLINE (mmol)
FiG. 4. Plots of(Vo -v)/V versus theconcentrationofL-proline at differentL-arginineconcentrations.
(Vo) is the control activity ofthe enzyme without L-proline and (v) the activity with the presence of
L-proline (calculated from the data of Fig. 2B). The calculated slope values (n) are shown.
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arginase assay system in the absence of
co-factors for these enzymes to cause the
observed inhibition of arginase. It has
been reported that proline inhibits puri-
fied arginasefrom liverandkidney (Hunter
and Downs, 1945; Kaysen and Strecker,
1973) and as well as arginase activity in
sheep liver homogenate (Kesava Rao,
Reddy and Swami, 1973). Thus, the
inhibition ofarginase by proline is not due
to the ornithine that might have formed
from the added proline but by proline
itself.
The arginase in mammary gland during
lactation does not function as part of the
urea cycle, because the cycle is incomplete
(Folley and Greenbaum, 1947; Yip and
Knox, 1972), and arginine can be con-
verted to proline involving the enzymes
arginase, ornithine aminotransferase and
Al-pyrroline 5-carboxylate reductase (Yip
and Knox, 1972). Proline formation from
arginine has been reported in bacterial
and animal systems (Costilow and Lay-
cock, 1971; Peisach and Strecker, 1962;
Strecker, 1965; Eliasson and Strecker,
1966; Hill and Chambers, 1967; Reddy
and Campbell, 1969; Kaysen and Strecker,
1973). Arginase has a quarternary struc-
ture (Hirch-Kolb and Greenberg, 1968;
Sorofand Kish, 1969; Carvajal et al. ,1971;
Vielle-Breitburd and Orth, 1972) and
shows sigmoid saturation curves as a
function of arginine concentration under
certain conditions (Cabello, 1967) which
are the two properties shown by most
enzymes susceptible for " end product "
inhibition. It is tempting to speculate
that the inhibition of arginase by proline
may be of regulatory importance, involv-
ing a feedback mechanism in mammary
tumours. Further work on this line may
prove worthwhile.
The authors are grateful to Dr iMrs) K.
J. Ranadive, Head, Biology Division for
her encouragement and interest in this
project, Dr S. R. R. Reddy of Poona
University for helpful discussions and
improvement of the manuscript and Mr
A. V. Bhat for technical assistance.
REFERENCES
ARCHIBALD, R. M. (1945) Colorimetric Determina-
tion of Urea. J. biol. Chem., 157, 507.
BACH, S. J. & LASNITZKI, I. (1947) Some Aspects of
the Role of Arginine and Arginase in Mouse
Carcinoma 63. Enzymologia, 12, 198.
BACH, S. J. & SIMoN-REuss, I. (1953) Arginase, an
Antimitotic Agent in Tissue Culture. Biochim.
biophys. Acta, 11, 396.
BHIDE, S. V. (1971) Arginase and Glucose-6-
phosphate Dehydrogenase Activities in Spon-
taneous Mammary Carcinogenesis. Br. J. Cancer,
25, 182.
CABELLO, J. (1967) Discussion, Enzymatic Aspects of
Metabolic Regulation. U.S. Natn. Cancer Inst.
Monog., 27, 297.
CAMPBELL, J. W. (1966) A Comparative Study of
Molluscan and Mammalian Arginases. Comp.
biochem. Physiol., 18, 179.
CARVAJAL, N., VENEGAS, A., OBSTREICHER, G. &
PLAZA, M. (1971) The Effect of Manganese on the
Quaternary Structure of Human Liver Arginase.
Biochim. biophys. Acta, 250, 437.
COSTILow, R. N. & LAYCOCK, L. (1971) Ornithine
Cyclase (Deaminating): Purification of a Protein
that Converts Ornithine to Proline and Definition
of the Optimal Assay Conditions. J. biol. Chtem.,
246, 6655.
DIXON, M. & WEBB, E. C. (1964) Enzymes. New
York/London: Academic Press. p. 324.
ELIASSON, E. E. & STRECKER, H. J. (1966) Arginase
Activity during the Growth Cycle ofChang's Liver
Cells. J. biol. Chem., 241, 5757.
FOLLEY, S. J. & GREENBAUM, A. L. (1947) Changes in
Arginase and Phosphatase Contents of the Mam-
mary Gland and Liver of Rat during Pregnancy,
Lactation and Mammary Involution. Biochem.
J., 41, 261.
GASIOROWSKA, I., POREMBSKA, Z. & MOCHNACHA, I.
(1969) Studies on Ox-brain Arginase. Acta
biochim. polonica, 16, 175.
GREENGARD, O., SAHIB, M. K. & KNOX, W. E. (1970)
Developmental Formation and Distribution of
Arginase inRatTissues. Archs. biochem. Biophys.,
137, 477.
HILL, D. L. & CHAMBERS, P. (1967) The Biosynthesis
of Proline by Tetrahymena Pyriformis. Biochim.
biophys. Acta, 148, 435.
HIRsCH-KOLB, H. & GREENBERG, D. M. (1968)
Molecular Characteristics of Rat Liver Arginase.
J. biol. Chem., 243, 6123.
HIRsCH-KOLB, H., HEINE, J. P., KOLB, H. J. &
GREENBERG, D. M. (1970) Comparative Physical-
chemical Studies of Mammalian Arginases.
Comp. biochem. Physiol., 37, 345.
HUNTER, A. & DowNs, C. E. (1945) The Inhibition of
Arginase by Amino Acids. J. biol. Chem., 157,
427.
KAYSEN, G. A. & STRECKER, H. J. (1973) Purifica-
tion and Properties of Arginase of Rat Kidney.
Biochem. J., 133, 779.
KESAVA RAO, K. V., REDDY, S. R. R. & SWAMI, K. S.
(1973) The Inhibition of Sheep Liver Arginase by
Some L-amino Acids. Int. J. Biochem., 4, 62.
KOSHLAND, D. R. (1970) The Molecular Basis of
Enzyme Regulation. In The Enzyme. Ed.
Boyer. Vol. 1. New York/London: Academic
Press. p. 341.
LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. &
RANDALL, R. J. (1951) Protein Measurement withINHIBITION OF ARGINASE BY PROLINE 135
the Folin-phenol Reagent. J. biol. Chem., 193,
265.
MEPHAM, T. B. & LINZELL, J. L. (1966) A Quantita-
tive Assessment of the Contribution of Individual
Plasma Amino Acids to the Synthesis of Milk
Proteins by the Goat Mammary Gland. Biochem.
J., 101, 76.
MEPHAM, T. B. & LINZELL, J. L. (1967) Urea Forma-
tion by the Lactating Goat Mammary Gland.
Nature, Lond., 214, 507.
MORA, J., TARRAB, R., MARTUSCELLI, J. & SOBERON,
G. (1965) Studies on the Advent of Ureotelism.
Factors that Render Hepatic Arginase of the
Mexican Axolotl able to Hydrolyse Endogenous
Arginine. Biochem. J., 110, 425.
PEISACH, J. & STRECKER, H. J. (1962) The Inter-
conversion of Glutamic Acid and Proline. V.
The Reduction of A2-Pyrroline 5-carboxylic Acid
to Proline. J. biol. Chem., 237, 2255.
RANADIVE, K. J., KAMAT, K. A., COUTINHO, T. G. &
KHANOLKAR, V. R. (1961) Incidence of Spontane-
ous Mammary Carcinoma in the New Strain of
Indian Laboratory Mouse. Ind. J. med. Res., 49,
562.
REDDY, S. R. R. & CAMPBELL, J. W. (1969) Arginine
Metabolism in Insects: Role ofArginase in Proline
Formation during Silkmoth Development. Bio-
chem. J., 115, 495.
SCHIMKE, R. T. (1964) The Importance of Both
Synthesis and Degradation in the Control of
Arginase Levels in Rat Liver. J. biol. Chem., 239,
3808.
SCHUTZ, G., CHOW, E. & FEIGELSON, P. (1972)
Regulatory Properties of Hepatic Tryptophan
Oxygenase. J. biol. Chem., 247, 5333.
SMITH, A. D., BENZIMAN, M. & STRECKER, H. J.
(1967) The Formation of Ornithine from Proline in
Animal Tissue. Biochem. J., 104, 557.
SMITH, T. C. & RICHTERICH, B. (1957) Arginase
Activity and Nucleic Acid Content in Mammary
Adenocarcinoma and Normal Homologous Tissue
of C3H Mice. Cancer Res., 17, 1006.
SOROF, S. & KIsH, V. M. (1969) On Molecular Sizes of
Rat Liver Arginase. Cancer Res., 29, 261.
STRECKER, H. J. (1965) Purification and Properties
of Rat Liver Ornithine 6-transaminase. J. biol.
Chem., 240, 1225.
VIELLE-BREITBURD, E. & ORTH, G. (1972) Rabbit
Liver Arginase: Purification, Properties and
Subunit Structure. J. biol. Chem., 247, 1227.
WIGGERT, B. 0. & COHEN, P. P. (1965) Substrate
Specificity of Crystalline Frog Liver Glutamate
Dehydrogenase. J. biol. Chem., 240, 4790.
YiP, M. C. M. & KNOX, W. E. (1972) Function of
Arginase inLactatingMammary Gland. Biochem.
J., 127, 893.